Marijuana stocks weekend investor roundup: Analysis of the week's most important events in the cannabis industry (January 12)
PotNetwork is pleased to bring you our Marijuana Stock Weekend from our partner publication Grizzle. Grizzle journalist and Head of Research Scott Willis covers the marijuana stock market in-depth, with over 12 years of institutional investment management experience in analyzing both debt and equity securities. He has held senior investment research roles at Credit Suisse and TD Asset Management. He’s also a Chartered Financial Analyst and has been featured on BNN Bloomberg and CBC. For more of Scott’s writing check out Grizzle - the language of new money.
Bottom Line: New management at Aphria and a coming rebuttal to the QCM allegations will clear the way for investors to chip away at the 85 percent stock price discount to peers. Aphria is once again an enticing target for consumer packaged goods companies or another licensed grower.
Bottom Line: We applaud the government's decision to allow anyone to open a cannabis retail store; however, the government is artificially constraining sales in 2019 by only allowing 25 stores to open in a province of 14 million. We now expect legal sales will disappoint expectations for all licensed producers at least in 2019 before edibles and vape pens are legalized.
Bottom Line: Canopy owns 27 percent of Canopy Rivers who owns 49 percent of Pharmhouse Inc, the owner, and operator of the greenhouse. This greenhouse will add 80,000 kg of capacity to the market, or 12 percent of Canadian cannabis demand, thereby increasing the likelihood of an oversupply in 2020.
Bottom Line: Greece is emerging as the Colombia of Europe. A low-cost place to grow cannabis that can then be exported and sold for a big markup to the rest of Europe. Even U.S. growers are starting to buy licenses in the country. Greece and Israel are the two largest competitors to Canada at this stage in the evolution of the global cannabis market.
Bottom Line: With CBD now effectively legal in North America, consumer brands are going to rush to incorporate it into many new products. Demand and prices for hemp-grown CBD will be strong this year before farmers ramp up plantings and drive the price of CBD down longer term.
Bottom Line: Keep in mind this study was done by an alcohol industry trade group, but it confirms what marijuana analysts expected: beer sales decline after cannabis legalization. Interestingly, wine and liquor sales are still growing, even in states that fully legalized cannabis.
Bottom Line: The focus of marijuana lobbyists this year is on pushing the STATES ACT through Congress, a bill to federally recognize each state's right to legalize cannabis. This bill is the best hope the U.S. cannabis industry has at the moment of relaxing federal rules.
Weekly marijuana stock performance
Positive sentiment continued to drive global marijuana stocks this week with the index up another 14 percent. U.S. operators performed in line with Canadian operators, both up 10 percent to 11 percent. Stocks are still well off their October highs, but this is another welcome positive week for cannabis investors.
Stocks are seeing a bounce back in the first quarter after selling off so heavily in November and December. The sentiment is so pessimistic it is hard to see stocks falling much further without additional negative earnings news or a global recession. A full buyout of a cannabis company by a consumer packaged goods company would be a strong positive catalyst for the entire industry.
From a fundamental perspective, be careful owning cannabis stocks into the next two quarters of earnings. A supply shortage and a government monopoly do not bode well for licensed producers' ability to meet or exceed earnings estimates.
Longer term, with the Canadian market, legalized we expect retail and wholesale price compression from a legal oversupply by the second half of 2019. Falling cannabis prices will pressure producer stocks later in 2019. After a shakeout, the remaining stocks will be better positioned as long-term buying opportunities.
- 12 Medical Marijuana Legalization Bills Filed for Texas in 2019
- 10 Marijuana-Related Bills on the List in Virginia
- Washington Governor Plans to Pardon Those with Marijuana Convictions
- Arkansas Gov. Warns Residents to Avoid Out-of-State Marijuana
- Auxly Cannabis Group Acquires CBD Company Inverell S.A.
- Emblem Launches Cannabis Oil Products Through Shoppers Drug Mart
- WeedMD Issues Ontario Greenhouse Expansion Update
- RavenQuest BioMed Acquires Majority Stake In Craft Cannabis Company For $1
- Denmark Begins Bulk Cannabis Shipments
- New Zealanders Projected to Vote Yes in Cannabis Referendum
- iCAN Secures Rights to Distribute Innovative Cannabis Patch
- Creso Pharma Expands Into Sri Lanka, Selling CBD Lozenge
More on PotNetwork
- EXCLUSIVE: Michael Raus of Kentucky Bluegrass Cannabis talks legalizing medical marijuana
- Neufeld out as Aphria posts middling Q2 financial report
- Wall Street names these marijuana stocks as the big winners for 2019
- EXCLUSIVE: With new Congressional Cannabis Caucus leaders, a more nuanced look at marijuana reform